On Tuesday, Zimmer Biomet Holdings Inc (NYSE: ZBH) opened higher 0.22% from the last session, before settling in for the closing price of $110.50. Price fluctuations for ZBH have ranged from $101.47 to $133.90 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company slipped by -1.20% over the past five years. Company’s average yearly earnings per share was noted 5.81% at the time writing. With a float of $198.80 million, this company’s outstanding shares have now reached $199.60 million.
Let’s look at the performance matrix of the company that is accounted for 18000 employees. In terms of profitability, gross margin is 66.29%, operating margin of 18.12%, and the pretax margin is 13.59%.
Zimmer Biomet Holdings Inc (ZBH) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Medical Devices industry is another important factor to consider. The insider ownership of Zimmer Biomet Holdings Inc is 0.14%, while institutional ownership is 92.84%. The most recent insider transaction that took place on May 31 ’24, was worth 1,474,582. In this transaction Group President, Asia Pacific of this company sold 12,857 shares at a rate of $114.69, taking the stock ownership to the 5,322 shares. Before that another transaction happened on Mar 07 ’24, when Company’s Group President, Asia Pacific sold 1,705 for $126.86, making the entire transaction worth $216,296. This insider now owns 18,179 shares in total.
Zimmer Biomet Holdings Inc (ZBH) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 5.81% per share during the next fiscal year.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Trading Performance Indicators
Check out the current performance indicators for Zimmer Biomet Holdings Inc (ZBH). In the past quarter, the stock posted a quick ratio of 0.70. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.90. Likewise, its price to free cash flow for the trailing twelve months is 20.06.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 5.25, a number that is poised to hit 2.30 in the next quarter and is forecasted to reach 8.59 in one year’s time.
Technical Analysis of Zimmer Biomet Holdings Inc (ZBH)
Zimmer Biomet Holdings Inc (NYSE: ZBH) saw its 5-day average volume 1.1 million, a negative change from its year-to-date volume of 1.49 million. As of the previous 9 days, the stock’s Stochastic %D was 55.16%. Additionally, its Average True Range was 2.04.
During the past 100 days, Zimmer Biomet Holdings Inc’s (ZBH) raw stochastic average was set at 60.83%, which indicates a significant increase from 38.49% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 21.48% in the past 14 days, which was lower than the 25.36% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $107.32, while its 200-day Moving Average is $113.97. Nevertheless, the first resistance level for the watch stands at $111.53 in the near term. At $112.32, the stock is likely to face the second major resistance level. The third major resistance level sits at $113.54. If the price goes on to break the first support level at $109.52, it is likely to go to the next support level at $108.30. The third support level lies at $107.51 if the price breaches the second support level.
Zimmer Biomet Holdings Inc (NYSE: ZBH) Key Stats
There are currently 199,074K shares outstanding in the company with a market cap of 22.05 billion. Presently, the company’s annual sales total 7,394 M according to its annual income of 1,024 M. Last quarter, the company’s sales amounted to 1,824 M and its income totaled 249,000 K.
